← Back to Search

Other

Vapocoolant Spray for Injection Pain in Breast Cancer Procedures

N/A
Recruiting
Led By Sanjit Tewari, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year.
Awards & highlights

Study Summary

This trial will study if a topical anesthetic spray reduces the pain of breast injections.

Who is the study for?
This trial is for adults over 18 who are undergoing a breast lymphoscintigraphy injection, which helps stage breast cancer. It's open to those able to consent and includes pregnant or lactating women. People with uncontrolled illnesses like diabetes, mental health conditions affecting study compliance, or allergies to vapocoolants can't participate.Check my eligibility
What is being tested?
The trial is testing if a cooling spray anesthetic called 'Nüm' can lessen the pain and anxiety when getting a breast injection for cancer staging. Participants will receive this vapocoolant before their scheduled procedure.See study design
What are the potential side effects?
Potential side effects of Nüm may include skin reactions at the application site such as redness, irritation, or allergic reactions in those sensitive to its ingredients.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Trial Design

1Treatment groups
Experimental Treatment
Group I: num VapocoolantExperimental Treatment1 Intervention
vapocoolant anesthetic spray (a spray that cools and numbs the skin) to control pain during minor surgical procedures (such as lancing boils, incisions, injections and IV placements) and minor sport injuries

Find a Location

Who is running the clinical trial?

Gilero, LLCUNKNOWN
M.D. Anderson Cancer CenterLead Sponsor
2,972 Previous Clinical Trials
1,787,287 Total Patients Enrolled
147 Trials studying Breast Cancer
63,256 Patients Enrolled for Breast Cancer
Sanjit Tewari, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the capacity of this medical trial in terms of recruitment?

"Correct. Data hosted on clinicaltrials.gov confirms that this medical experiment, which was initially posted on March 1st 2023, is actively recruiting participants. Approximately 30 individuals must be enrolled from a single site."

Answered by AI

Are enrollees still being recruited for this experiment?

"Affirmative. The clinicaltrials.gov portal denotes that this trial, which was initially posted on March 1st 2023, is actively accepting participants. Approximately 30 patients need to be recruited from one of the given medical sites."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
MD Anderson Cancer Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

To make quick money.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

How long does it take ?
PatientReceived no prior treatments
~14 spots leftby Apr 2025